BioPharma Credit (LON:BPCR) Trading Up 0.5% - Here's Why

Key Points

• BioPharma Credit shares increased by 0.5% to GBX 0.87 ($0.01), with approximately 223,748 shares traded, marking a significant 74% decrease in volume from the average.
• The company, founded in 2016, focuses on investing in interest-bearing debt assets backed by royalties or cash flows from approved life sciences products.
• BioPharma Credit has a market capitalization of £1.04 billion, a PE ratio of 9.91, and a beta of 0.22, indicating lower volatility relative to the market.

BioPharma Credit (LON:BPCR - ) shares rose 0.5% on Tuesday . The stock traded as high as GBX 0.87 ($0.01) and last traded at GBX 0.87 ($0.01). Approximately 223,748 shares traded hands during mid-day trading, a decline of 74% from the average daily volume of 851,581 shares. The stock had previously closed at GBX 0.87 ($0.01).

BioPharma Credit Stock Performance

The company has a 50 day moving average of GBX 0.88 and a two-hundred day moving average of GBX 0.87. The stock has a market capitalization of £1.04 billion, a PE ratio of 9.91 and a beta of 0.22.

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.